Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Adalimumab Antibody ELISA Kit

The Human Adalimumab Antibody ELISA Kit (ABIN8089335) is a Colorimetric ELISA Kit designed to quantify Human Adalimumab Antibody.
Catalog No. ABIN8089335
$643.65
Plus shipping costs $50.00
96 tests
Shipping to: United States
Delivery in 13 to 17 Business Days

Quick Overview for Adalimumab Antibody ELISA Kit (ABIN8089335)

Target

Adalimumab Antibody

Reactivity

  • 2
  • 1
Human

Detection Method

Colorimetric

Method Type

Sandwich ELISA

Application

ELISA

Sample Type

Plasma, Serum
  • Purpose

    Human Anti-Adalimumab antibody ELISA kit

    Analytical Method

    Qualitative

    Specificity

    Specifically binds with Anti-Adalimumab-Ab , no obvious cross reaction with other analogues.

    Material not included

    • Microplate reader (wavelength: 450nm)
    • 37 °C incubator (CO2 incubator for cell culture is not recommenced.)
    • Automated plate washer or multi-channel pipette/5 mL pipettor
    • Precision single (0.5-10μL
    • 5-50μL
    • 20-200μL
    • 200-1000μL) and multi-channel pipette with disposable tips(Calibration is required before use.)
    • Sterile tubes and Eppendorf tubes with disposable tips
    • Absorbent paper and loading slot
    • Deionized or distilled water
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    Sandwich ELISA, Double antigen

    Assay Time

    4 h

    Plate

    Pre-coated

    Restrictions

    For Research Use only
  • Handling Advice

    Avoid direct light exposure to antibody solutions

    Storage

    4 °C

    Storage Comment

    Store sealed Kit at 2-8° C. Do Not Cryopreserve. Store ELISA Microplate for 1 month at 2-8°C, Store for 12 month at -20°C. Put the leftover strips into a sealed foil bag with the desiccant

    Expiry Date

    12 months
  • Target

    Adalimumab Antibody

    Alternative Name

    Anti-Adalimumab

    Target Type

    Anti-Drug Antibody

    Background

    Anti-Adalimumab
You are here:
Chat with us!